<DOC>
	<DOCNO>NCT02604264</DOCNO>
	<brief_summary>To assess positive blood culture ( PBCs ) hemodialysis central venous catheter ( CVC ) patient use two FDA clear device : ClearGuard HD end cap compare conventional end cap .</brief_summary>
	<brief_title>Product Evaluation Effectiveness ClearGuardâ„¢ HD End Cap</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>All patient dialyze central venous catheter Known allergy chlorhexidine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>